![](/Content/Images/icons/rate.png?v=2511129)
![](/Content/Images/icons/ask_expert.png?v=2511129)
![](/Content/Images/icons/request.png?v=2511129)
![](/Content/Images/icons/favorites.png?v=2511129)
![](/Content/Images/icons/create_parts_list.png?v=2511129)
Parts List
![](/Content/Images/icons/send_email.png)
Friend
![](/Content/Images/icons/print.png?v=2511129)
Find methods for your needs
![](/Content/Images/icons/search_help.png?v=2511129)
Description
A UHPLC workflow for mAb aggregate analysis that operates continuously for weeks.Market: | BioPharma |
Keywords: | Protein, Vanquish, Biopharma, MAbPac SEC-1, Biocompatible UHPLC, Vanquish Flex UHPLC System, Bevacizumab, protein aggregation analysis, Biopharmaceuticals, Vanquish Flex, NIBRT, Vanquish Flex UHPLC |
Matrix: | Buffer |
Author: | Alexander Ley |
Affiliation: | Thermo Fisher Scienitific, NIBRT |
For Research Use Only. Not for use in diagnostic procedures.